CROs/Service Providers

WCCT Global, Verified Clinical Trials enhance clinical trials database registry

Monday, January 7, 2013 11:24 AM

WCCT Global, a full service CRO supporting phase I-IV development, has collaborated with Verified Clinical Trials (VCT), the largest national clinical trials database registry in the U.S., to help them enhance the capabilities of the VCT Clinical Trials Database Registry system.

More... »

Illumina strengthens reproductive health segment with acquisition of Verinata Health

Monday, January 7, 2013 10:26 AM

Illumina, a developer, manufacturer and marketer of life science tools and integrated systems, has signed a definitive agreement to acquire Verinata Health, a provider of non-invasive tests for the early identification of fetal chromosomal abnormalities, for consideration of $350 million, plus up to $100 million in milestone payments through 2015.

More... »

Clinical Network Services acquires Beltas

Monday, January 7, 2013 09:00 AM

Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has acquired the business assets of its New Zealand CRO partner Beltas, based in Auckland.

More... »

Parexel acquires Liquent

Wednesday, January 2, 2013 09:49 AM

Parexel International has acquired all of the outstanding equity securities of Liquent, a global provider of Regulatory Information Management (RIM) solutions. Liquent provides an integrated platform of software solutions for regulatory submissions and product registration management, as well as a range of complementary business process outsourcing capabilities.

More... »

Synteract to acquire Harrison Clinical Research

Thursday, December 20, 2012 10:37 AM

CRO Synteract, a portfolio company of San Francisco-based Gryphon Investors, has agreed to acquire Harrison Clinical Research (HCR).

More... »

WuXi PharmaTech, PRA form joint venture for Chinese market

Thursday, December 20, 2012 10:32 AM

CRO WuXi PharmaTech, with operations in China and the U.S., and CRO PRA have signed a joint venture agreement to offer a broad platform of phase I-IV clinical trial services in China, Hong Kong and Macau, including clinical trial monitoring, project management, regulatory strategy and submissions, data management, biostatistics, drug safety reporting and medical monitoring.

More... »

ZeinCRO expands to 14 CSEE countries total

Tuesday, December 18, 2012 11:35 AM

ZeinCRO, a CRO based in Europe, has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.

More... »

23andMe raises more than $50M in new financing

Monday, December 17, 2012 02:37 PM

23andMe, a personal genetics company based in Mountain View, Calif., has raised more than $50 million in a Series D financing. Participants in the financing include Yuri Milner, a new investor, as well as existing investors Sergey Brin, 23andMe CEO Anne Wojcicki, New Enterprise Associates, Google Ventures and MPM Capital. This investment will help the company achieve its growth goal of one million customers.

More... »

Warnex completes sale of bioanalytical services to CRO Biotrial

Monday, December 17, 2012 11:06 AM

Warnex, a life sciences company, has successfully completed the sale of its bioanalytical services division to Biotrial Research, a privately-owned CRO headquartered in France.

More... »

AMRI, GE Healthcare extend long term supply relationship

Monday, December 10, 2012 01:16 PM

AMRI, a global contract research and manufacturing organization, has extended its commercial supply relationship with GE Healthcare for Aminobisamide Hydrochloride (ABA).

More... »